Clinical Pharmacokinetics of Phenylbutazone
- 1 January 1978
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 3 (5), 369-380
- https://doi.org/10.2165/00003088-197803050-00003
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Inhibition of DNA synthesis in cultured human lymphocytes by phenylbutazone and oxyphenbutazoneJournal of Pharmacy and Pharmacology, 1976
- Metabolism of phenylbutazone in man.1976
- Pharmacodynamic and Pharmacokinetic Drug Interactions with Coumarin AnticoagulantsDrugs, 1976
- Decreased drug binding in serum from patients with chronic hepatic diseaseEuropean Journal of Clinical Pharmacology, 1976
- Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.British Journal of Clinical Pharmacology, 1975
- Untersuchungen zum Einfluß der Urämie auf die Metabolisierung von Phenylbutazon und Aminophenazon beim MenschenKlinische Wochenschrift, 1972
- MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN*Annals of the New York Academy of Sciences, 1971
- Über das Hydrolysegleichgewicht von Phenylbutazon (Butazolidin®)Helvetica Chimica Acta, 1970
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968
- [Blood level determination of butazolidine and tanderil from a drop of capillary blood].1965